ValueAct Surges as the Hedge Fund Benefits From Fox Battle

The activist hedge fund firm has seen big gains from its positions in 21st Century Fox and Valeant Pharmaceuticals.

Steve Taub December 20, 2025

Twenty-First Century Fox headquarters, New York

(Alexander F. Yuan/Bloomberg)

The battle between Walt Disney Co. and Comcast Corp. to buy assets from 21st Century Fox and Sky has been lucrative for Fox investors. And one of them is ValueAct Capital. The San Francisco-based hedge fund firm is one of the top-performing activists this year

To continue reading, subscribe now to Premium Journalism. Already a subscriber? login.

Contact Info

New York
1270 Avenue of the Americas, Suite 1100
New York, NY 10020
P: +1 212 224 3300

London
4 Bouverie Street
London EC4Y 8AX
P: +44 207 779 8888

Hong Kong
Unit 2488, 24/F
Lee Garden One,
33 Hysan Avenue
Causeway Bay, Hong Kong
P: +852 2912 8001

Corporate

About Us

Leadership Team

Careers

II Press Room

Digital

Masthead

Thought Leadership

Display Advertising

Reprints

FAQs

Events

Events Calendar

Memberships

Subscription

Subscribe to Premium

Register

Register for Free Account

Newsletters

Sign up for II newsletters

© 2025 Institutional Investor LLC. All material subject to strictly enforced copyright laws. Please read our Terms & Conditions, Modern Slavery Act Transparency Statement, Accessibility Statement and Privacy Policy before using the site.

develop build:2025-12-18 Login